Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Agenus Inc (AGEN)

Agenus Inc (AGEN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Agenus to Host End-of-Year Stakeholder Webcast Featuring GI Oncology Leaders and Progress of BOT/BAL Business Wire - Wed Nov 19, 3:01PM CST

Webcast on Wednesday, December 3, 2025 at 4:00 p.m. ET

AGEN : 4.06 (-2.64%)
Agenus Appoints Dr. José Iglesias as Chief Medical Affairs Officer to Guide Global Medical Affairs and Early-Access Programs, Including France’s AAC Business Wire - Tue Nov 18, 7:41AM CST

Agenus Inc. (Nasdaq: AGEN) , a leader in immuno-oncology innovation, today announced the appointment of José Iglesias, M.D. as ...

AGEN : 4.06 (-2.64%)
Agenus: Q3 Earnings Snapshot AP - Mon Nov 10, 6:37AM CST

Agenus: Q3 Earnings Snapshot

AGEN : 4.06 (-2.64%)
Agenus Reports Q3 2025 Results Showcasing Clinical and Regulatory Advances Business Wire - Mon Nov 10, 6:30AM CST

France grants reimbursed access with patients having commenced treatment Two-year BOT/BAL survival presented at ESMO spanning more than five cancers in...

AGEN : 4.06 (-2.64%)
Agenus to Provide Corporate Update and Third Quarter 2025 Financial Report Business Wire - Wed Nov 5, 12:47PM CST

Agenus Inc. (“Agenus”) (Nasdaq: AGEN ), a leader in immuno-oncology, today announced that the Company will release its third quarter 2025 financial results before the market...

AGEN : 4.06 (-2.64%)
Agenus Reports 39% of Patients Alive at Two-Years with BOT/BAL Across Multiple Refractory Solid Tumors at ESMO 2025 Business Wire - Fri Oct 17, 7:00AM CDT

Durable survival in heavily pretreated patients, including those who failed prior immunotherapy and with active liver metastases Signals of tumor agnostic...

AGEN : 4.06 (-2.64%)
Agenus to Host October Stakeholder Briefing Showcasing BOT/BAL Global Momentum and Post-ESMO Insights Business Wire - Thu Oct 16, 6:48AM CDT

Webcast on Tuesday, October 21, 2025 at 4:00 p.m. ET

AGEN : 4.06 (-2.64%)
Agenus Secures $10M Promissory Note with Zydus Tipranks - Fri Oct 10, 3:45PM CDT

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Agenus (...

AGEN : 4.06 (-2.64%)
France Grants Reimbursed Compassionate Access (AAC) for Agenus’ BOT/BAL in Refractory MSS Metastatic Colorectal Cancer Business Wire - Tue Sep 9, 6:43AM CDT

Agenus Inc. (Nasdaq: AGEN), a leader in immuno‑oncology, today announced its investigational combination botensilimab plus balstilimab (BOT/BAL) is now available to eligible patients with refractory...

AGEN : 4.06 (-2.64%)
Agenus to Participate in the H.C. Wainwright 27th Annual Global Investment Conference Business Wire - Fri Sep 5, 7:52AM CDT

Agenus Inc . (Nasdaq: AGEN), a leader in immuno-oncology, today announced that the company will participate in the H.C. Wainwright 27th Annual Global Investment Conference, taking place...

AGEN : 4.06 (-2.64%)

Barchart Exclusives

Is This Dividend Stock a Buy for 2026 After Rising 265% in 2025? Barchart - Thu Dec 4, 6:30PM CST
Anglogold Ashanti shares have soared this year amid a spike in gold prices. While the shares might take a breather for now, it is a buy-on-the-dip candidate for 2026. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot